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Background: Drug-induced liver injury is a major health problem that challenges not only health care professionals
but also the pharmaceutical industry and drug regulatory agencies. The possible hepatoprotective effect of the
administration of mulberry ethanolic extract (MUL) leaves against hepatotoxic effect of the anti-rheumatic drug,
methotrexate (MTX) was evaluated in this study both vivo (using animal models) and in vitro (human hepatoma
HepG2 cells).
Methods: In the in-vivo study, 20 male albino rats were equally assigned into four groups; control group received
distilled water orally; MUL treated-group received 500 mg/kg/day of MUL extract; MTX treated-group was injected
with a single dose of 20 mg/kg MTX intraperitoneally on the 4th day; MUL-MTX treated-group received the previously
mentioned doses of MUL and MTX (both control and MUL treated groups were administered a single dose of a
physiological saline i.p.). At the end of the experimental period (14 days) activities of alanine transaminase (ALT),
aspartate transaminase (AST), alkaline phosphatase (ALP) and lactate dehydrogenase (LDH) as well as total serum
protein (TP) and albumin (ALB) levels were evaluated to assess liver function.
Results: A marked reduction in the viability of HepG2 cells was observed after 48 h with IC50 equal to 14.5 μg/mL of
MUL administration. Treating the animals with MUL in combination with MTX mitigated liver injury, causing a
significant reduction in activities of AST, ALT, ALP and LDH as compared to the MTX-group. The liver architecture
revealed more or less normal appearance with the combined treatment when compared with MTX treatment alone.
Conclusions: This study recommends that the co-administration of MUL with MTX that may have therapeutic benefits
against MTX-hepato-cytotoxicity.
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Drug-induced liver injury is a major health problem that
challenges not only health care professionals but also the
pharmaceutical industry and drug regulatory agencies
[1]. The drug-induced injury could be induced through
different ways including direct toxic effect; immunological
reaction or through active metabolite that is formed by the
drug [2]. Methotrexate (MTX) drug, a structural analogue
of folic acid, is widely used as anti-an rheumatic, cytotoxic
chemotherapeutic agent for malignancies as well as in the
treatment of various inflammatory diseases [3, 4]. MTX isCorrespondence: hendmaarof1@yahoo.com
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and stored in polyglutamated form, thus decreases folate
levels by the inhibition of dihydrofolate reductase [5]. The
widespread use of MTX and it is long-term therapy has
attracted physicians’ attention to the possible adverse reac-
tions of MTX [6].
Traditional plant medicines or herbal formulations
might offer a natural key to hepatoprotective effect against
xenobiotic/drug [7]. Morus nigra (Moraceae) is widely
distributed in Asia, Africa, Europe, and America, and it
is commonly known as black mulberry. It has been re-
ported that Morus nigra is antioxidant and has protective
action against oxidative damage to membranes and biomol-
ecules [8, 9]. Important phyto-chemical constituents e.g.tributed under the terms of the Creative Commons Attribution License (http://
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plant [8, 10]. The flavonoids compound has shown to have
hepatoprotective activity as reported previously by Adedosu
et al. [11]. In addition, Naderi et al. [12] and Mallhi et al.
[13] investigated the hepatoprotective effects of Morus
nigra in both human and animals.
Therefore, the aim of the present work is to investigate
the hepatoprotective effects of black mulberry leaf extract
against the possible MTX-induced liver injury in human
hepatoma HepG2 cells as well as in male albino rats.
Methods
Chemicals and plant materials
Methotrexate was purchased from Orion Corporation,
Espoo, Finland. Other chemicals and reagents were of
high analytical grade and were bought from standard
commercial suppliers. The leaves of mulberry plant were
collected from Ismaillia government, Egypt. The plant ma-
terials were identified from a taxonomist, Department of
Botany, Faculty of Science, Suez Canal University, Ismailia,
Egypt.
Preparation of the plant extracts
Plant material was collected from mulberry trees which
cultivated in Faculty of Science, Suez Canal University,
Ismailia, Egypt, in March 2014 and were identified and
authenticated by Botany Department, Faculty of Science,
Suez Canal University on the basis of taxonomic charac-
ters and by direct comparison with the herbarium speci-
mens with a voucher number (HERBFAS#5) available at
the herbarium of Botany department. The plant extract
was prepared as described before in [14, 15] with minor
modifications. Briefly, the leaves of Morus nigra were
washed, air-dried and powdered. The dried powder was
extracted with 50 % hydro-ethanol solution for 48 h.
The marc was further extracted by 50 % hydro-ethanol
for 48 h to obtain the extract. The extract was then fil-
tered and evaporated to dryness under reduced pressure
on a rotary evaporator. The yield of ethanolic extract of
Morus nigra leaves was found to be 10.2 % w/w.
In vitro study: cytotoxicity evaluation using viability assay
HepG2 cell line (human cell line of a well differentiated
hepatocellular carcinoma isolate from a liver biopsy of a
male Caucasian aged 15 years) was obtained from the
American Type Culture Collection (ATCC). Cells were
cultured in Dulbecco’s Modified Eagle Medium (DMEM)
with Earle’s salts supplemented with 10 % fetal bovine
serum (Bio-Whittaker, Lonza, Belgium), 2 m M L-glu-
tamine, 50 IU/mL streptomycin and maintained at 37 °C
in humidified 5 % CO2.
Doxorubicin hydrochloride, an anticancer drug (VHB,
Medi-sciences, Ltd, India) was used in the present study
as a positive control. The drug was used within 15 daysof purchase and was stored at the prescribed temperature.
The dilutions were made in phosphate buffer saline (PBS).
Cell viability was assessed after 48 h of incubation with
mulberry leaf extract or doxorubicin hydrochloride (50.0,
25.0, 12.50, 6.25, 3.12, 1.56 μg/mL) by crystal violet stain-
ing which dyes cellular nuclei. The staining was performed
according to Henriksson et al. [16] method with slight
modifications. Briefly, the cells were harvested, suspended
in the growth medium mentioned above and seeded on
96-well plates (Falcon, NJ, USA) of 1 × 104 cells per
well. After 24 h, the cells were incubated at 37 °C in a
humidified incubator with 5 % CO2 for 48 h with mul-
berry leaf extract or doxorubicin hydrochloride. The
medium was then removed and the cells were fixed in
situ with 4 % formaldehyde solution in PBS for 30 min
at room temperature. The cells were washed twice
with PBS (pH 7.4) and stained with 0.5 % crystal violet
dissolved in 25 % aqueous solution of methanol for
5 min at room temperature. Unbound dye was washed
out with deionized water and the cells allowed to air dry.
The dye was solubilized in 33 % aqueous solution of acetic
acid while shaking for 30 min at room temperature. Op-
tical density (OD) was measured with a microplate reader
(TECAN, Inc.), at wavelength of 490 nm.
In vivo study
Animals and experimental design
Twenty male albino rats weighing 180–200 g obtained from
the animal house of National Research Center, Egypt
were used. Rats were housed in an air-conditioned room
with 12-h light and dark cycles at 22 ± 2 °C. They were fed
standard rodent diet with tap water ad libitum. Animals
were divided into 4 groups, 5 rats each. The experiment
was performed in accordance with the internationally ac-
cepted standard ethical guidelines for laboratory animal
use and care as described in the European Community
guidelines [17].
The first group ‘control-group’ was untreated with neither
MTX nor MUL. The second group ‘MUL-group’ received
mulberry leaf extract intragastrically at a dose of 500 mg/kg
daily for 14 days [13]. The third group was injected
with a single dose of MTX (20 mg/kg, I.P.) [18] at the
fourth day of the experiment, ‘MTX-group’. The fourth
group ‘MUL+MTX-group’ was administrated with MUL
and MTX at the same does, described in second and third
groups, respectively. Both control and MUL treated groups
were administered a single dose of a physiological sa-
line (IP). All animal treatments were conducted daily
for 14 days.
Sample collection
At the end of the experiment, rats in all groups were
anaesthetized with ether and blood samples were with-
drawn from retro-orbital venous plexus by a capillary tube.
Fig. 1 Effects of mulberry leaf extract on HEPG2 cell line using
viability assay
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4000 rpm for 10 min and stored at −20 °C until the bio-
chemical analyses were performed. The animals were then
euthanized by cervical dislocation before sacrificing. Livers
were dissected out, blotted, dried and weighed. For each
group livers were fixed in 10 % formalin saline for routine
histopathological examination.
Assessment of hepatic function markers
The activities of alanine aminotransaminase (ALT) and
aspartate aminotransaminase (AST) were determined in
serum using commercial kits (Human Company, Germany,
Cat. No. EC 2.6.1.2), based on kinetic method of Schumann
et al. [19]. Lactate dehydrogenase (LDH) activity was evalu-
ated using the method of Young [20] (Biosystems Com-
pany, Spain, Cat. No. M11580i-10). Alkaline phosphatase
(ALP) activity was determined using commercial kit (Pointe
Scientific, Inc. Brussels, BELGIUM, Cat. No. P803-A7516-
01), based on the recommended method of Tietz [21].
Total protein (TP) and albumin (ALB) levels were mea-
sured using commercial kits (Human Company, Germany,
Cat. No. INF. 157001. GB and INF.156001.D, respectively).
Morphometric and histopathological study
Determination of hepatosomatic index The gross liver
weight of each rat was determined using an electronic
balance immediately after the freshly harvested liver was
blotted dry. A hepatosomatic index (HSI) was computed
by expressing the liver weight as a percentage of the rat’s
body weight at the end of the experiment [22].
Histopathological evaluation and image analysis Liver
specimens were quickly removed, immersed in 10 % for-
malin, dehydrated and embedded in paraffin, sectioned at
4 μm, stained with hematoxylin and eosin (H&E) and eval-
uated by light microscopy. The histopathological scoring
analysis was performed according to Lobenhofer et al. [23],
the assessment was expressed as the sum of the individual
score grades from 1 (minimal), 2 (mild), 3 (moderate), to 4
(marked) for each of the following parameters from liver
sections: hepatocyte necrosis, fibrosis (collagen deposition),
cellular infiltration, hepatocyte apoptosis and hepatocyte
fatty change.
Identifying and quantifying liver fibrosis The liver tis-
sue samples were fixed in 10 % neutral buffered formalin,
embedded in paraffin, sectioned at 4 μm thicknesses and
stained with Goldner’s Masson Trichrome for detection of
collagen fibers.
Ten colored histological images resulting from Goldner’s
Masson Trichrome staining were captured by a digital cam-
era (Canon Power Shot A640) and digitalized at 1024 ×
768 pixel, 24 bit/pixel resolution, from 10 non-overlapping
random fields per histological section in randomly chosenthree animals from each group, at ×200 magnification. The
digital images were processed using the image J (version
1.32j, the national institution of health, USA) analysis soft-
ware. The image J automatically identifies and isolates
fibrotic areas according to their staining (green) and then
measures the area occupied by fibrosis with respect to the
total liver area examined [24]. The percentage of area
occupied by fibrosis (PF) is then determined, according
to the following equation, PF = (labeled fibrosis area/total
image area) × 100 [25].
Statistical analysis
All values were expressed as mean ± standard error (X ±
SE). Comparisons of evaluated parameters between the ex-
perimental groups were made using the one-way analysis of
variance (ANOVA). Post-hoc comparisons were conducted
by Duncan procedure. Statistical analyses were performed
with the Statistical Package for the Social Sciences (SPSS),
version 20.0 for windows (SPSS Inc., Chicago, IL, USA),
with a significant difference of p < 0.05.
Results
Influence of MUL on viability of HepG2 cell line
The effects of ethanolic extract of Mulberry leaf against
human HepG2 cells are shown in Fig. 1. Concentration
above 12.5 μg/mL resulted in a marked reduction in cell
viability. The percentage of growth inhibition was found
to increase with increasing concentration of the test
compound. The IC50 values of MUL and Doxorubicin
hydrochloride found to be 14.5 and 1.2 μg/mL respectively.
Effect of MUL extract on MTX-induced hepatotoxicity
The biochemical parameters of AST, ALT, ALP, LDH activ-
ities as well as the levels of TP and ALB were measured to
estimate the general liver function. As shown in Table 1,
animals treated with MUL did not show noticeable changes
compared with control group. Whereas, the administration
of MTX induced hepatotoxicity indicated by the increase in
Table 1 Effects of ethanol extract of mulberry on various biochemical parameters in rats with chemically induced liver toxicity
Groups ALT activity (U/l) AST activity (U/l) ALP activity (U/l) LDH activity U/l Total protein g/dl Albumin g/dl Albumin to Globulin Ratio.
(A/G) g/dl
Control 40.50 ± 3.28 93.25 ± 2.36 66.00 ± 7.12 470.50 ± 9.14 7.100 ± 0.163 4.13 ± 0.16 1.50 ± 0.04
MUL 19.50 ± 1.19 62.00 ± 5.79 36.25 ± 9.25 422.25 ± 12.25 7.00 ± 0.73 4.03 ± 0.06 1.43 ± 0.03
MTX- 71.00 ± 12.34a 135.75 ± 25.55a 110.25 ± 13.82a 1607.25 ± 121.57a 6.63 ± 0.10 3.83 ± 0.33 1.20 ± 0.08
MUL+ MTX 21.75 ± 3.25b 82.00 ± 6.00b 99.00 ± 7.55b 393.00 ± 87.18b 6.93 ± 0.048 3.70 ± 0.29 1.35 ± 0.23
Values are expressed as mean ± S.E. for five rats in each group
aSignificantly different from control using one way ANOVA followed by Duncan
bSignificantly different compared with MTX-treated group using one way ANOVA followed by Duncan
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group. Serum total protein and albumin levels displayed no
significant difference as compared with control. On the
other hand, rats treated with both MUL and MTX in com-
bination had significant decrease in ALT, AST and LDH ac-
tivities compared with MTX group (p < 0.05).
Liver-body weight ratio (HSI) has been found to be
significantly increased after MTX administration as com-
pared with control group. However, there was no significant
difference in HSI of MUL-MTX group when compared
with control group, while there was apparent significant
decrease in HSI values comparing MUL-MTX group
with MTX-treated animals (Fig. 2).
Results from histopathological studies provided support-
ive evidence for the biochemical analysis. The ‘control
group’ (Fig. 3a–b) and ‘MUL group’ (Fig. 3c–d) showed
a normal appearance of the liver cells, whereas the
MTX-treated animal showed changes in hepatic architec-
ture with centrilobular hepatic necrosis, cloudy swelling of
hepatocytes and cell infiltration associated with fibrosis
around the portal tract (Fig. 3e and f). Treatment with
500 mg/kg b.wt ethanol extract of MUL showed moderate
enhancement in protecting liver cells from MTX-injury as
shown in Fig. 3g and h.Fig. 2 Effect of mulberry leaf extract on the hepatosomatic index
(HSI) of MTX treated rats. Results are expressed as mean ± S.E. (n = 5),
aSignificantly different from control using one way ANOVA followed
by Duncan. bSignificantly different compared with MTX-treated group
using one way ANOVA followed by Duncan. Hepatosomatic index:
(Liver weight × 100)/body weightThe microscopic damage score for each group was de-
termined, and illustrated in Fig. 3i–m. The hepatocyte
degeneration for ‘MTX group’ (22.7 ± 0.33) and ‘MTX-MUL
group’ (5.0 ± 1.15) was significantly increased compared
with the ‘control group’ (Fig. 3i). The congestion in
‘MTX group’ (15.0 ± 1.00) was significantly increased,
compared with the control group (0.00 ± 0.00), while
there was no significant difference between MTX-MUL
group and control group observed (Fig. 3j). The leukocyte
infiltration in MTX group (25.33 ± 1.76) was significantly
increased as compared with control group. However, there
was no significant difference between MTX-MUL (2.67 ±
0.88) group and control group (0.00 ± 0.00) (Fig. 3k). The
fibrosis in MTX group (35.0 ± 0.58) was significantly
increased than control group, whereas there was no
significant difference between MTX-MUL group (2.33 ±
1.45) and the control group (0.00 ± 0.00) (Fig. 3l). The
total histopathology score for the liver was significantly
increased in MTX-treated group (120.3 ± 1.76) com-
pared with the control group (18.0 ± 3.21) (Fig. 3m),
with no significant difference between MUL-group and
control group.
The results obtained from histological sections of
livers with Masson’s Trichrome staining for control and
MUL-treated rats were similar (Fig. 4a and b). The clas-
sic lobule was hexagonal in shape. The portal tract area
was located at each corner of the lobule, and was com-
posed of thin connective tissue septum containing few
collagen fibers. Embedded in the portal tract there were
a terminal portal venule, a terminal hepatic arteriole, an
interlobular bile ductule and fine lymph vessels. The
livers of the MTX treated animals showed an apparent
increase in the amount of collagen fibers particularly
around blood vessels in portal tract (Fig. 4c). Section of
liver tissue from animals that were treated with combin-
ation of MTX and MUL showed less amount of collagen
fibers (Fig. 4d) as compared with MTX-group. Quantifi-
cation of fibrosis using semi-automated image analyses
revealed a significant increase of fibrosis in liver of MTX-
treated rats compared to control (19.50 ± 6.69 % vs1.33 ±
1.51 %, Table 2), and a significant decrease in MTX-MUL
group compared to MTX-treated rats (2.64 ± 2.15 vs
19.50 ± 6.69, Table 2).
Fig. 3 Hematoxylin and eosin-stained sections of rat liver: a and b Shows the general morphology of the classic liver (hepatic) lobule. It is roughly
hexagonal in shape. At the center of the lobule is the central vein (CV). The hepatocytes (H) are organized into anastomosing cords or plates, one
cell thick, separated by anastomosing hepatic sinusoids (S).; c and d Mulberry treated rat showed normal structure of heptic tissue. e and f Methotrexate
(20 mg/kg) treated rat; e shows focal area of necrosis (head arrow) around the central vein where the cell boundaries were lost. f Shows heavy
cell infiltration associated with fibrosis around the portal tract (arrow) and cloudy swelling of hepatocytes (CW). g and h Liver section from rats
pre-treated with 500 mg/kg mulberry leaf extract and challenged with MTX showed preserved periventricular (cv) structure, absence of fibrosis, while
noticing mild hydropic degeneration (HD) of hepatocytes. Bar = 100 μm. Bars represent mean ± SEM of histopathological scoring of the effect
of mulberry leaf extracts on induced MTX-hepatic toxicity. a indicates significantly different values when comparing control animals, p < 0.05. b indicates
significantly different values when comparing to MTX-group, p < 0.05
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Methotrexate (MTX), a folic acid antagonist, is widely
used as a cytotoxic chemotherapeutic agent for severalmalignancies and various inflammatory diseases, which
may lead to liver hepatotoxicity due to the depletion of the
folate [26]. The results of the present study indicate that
Fig. 4 Masson’s Trichrome staining of collagen within the liver tissue. a, b Shows normal distribution of collagen fibers, stained green, around a
portal tract in control and MUL-treated group, respectively. c Shows marked increase in collagen fibers around the blood vessels in the portal
tract in MTX-treated group. d Shows normal distribution of collagen fibers, stained green, around a portal tract in MUL-MTX group, (Masson’s
trichrome, ×200)
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ities. These results are in agreement with Tunali-Akbay
et al. [27] who demonstrated that rats treated with MTX
exhibited a toxic effect on liver where it provoked a not-
able elevation in serum activities of ALT and AST. ALT is
a cytosolic enzyme of the hepatocyte and its increased
serum activity reflects a leakage in plasma membrane
permeability, which in turn, associated with cell death.
ALT is considered to be one of the best indicators of liver
necrosis [28]. Many authors describe the mechanism
through which MTX induced hepatotoxicity. Jahovic et al.
[26] and Al-motabagani et al. [29] reported that MTX can
bind to the enzyme hydrofolic reductase, which bansTable 2 Morphometric quantitative measurements of liver
fibrosis in animal groups stained with Masson’s trichrome stain
Groups Area %
Control 1.33 ± 1.51
Mulberry-Treated 1.22 ± 0.92
MTX-treated 19.50 ± 6.69a
Mulberry + MTX 2.64 ± 2.15b
Area %: represent the degree of hepatic fibrosis, the results are represented as
mean value ± SE
aSignificantly different from control using one way ANOVA followed
by Duncan
bSignificantly different compared with MTX-treated group using one way
ANOVA followed by Duncanconversion of folic acid to folinic acid causing block in
some amino and nucleic acids synthesis. This might
lead to damage of organelles and plasma membranes of
hepatic parenchymal cells interfering with their func-
tion and allowing leakage of enzymes. Moreover, Kose
et al. [30] stated that MTX caused increasing in malon-
dialdehyde (MDA) and myeloperoxidase (MPO) levels
leading to lipid peroxidation which is considered to be
an important cause of destruction and damage to cell
membranes, which has been suggested to be a contribut-
ing factor to the development of methotrexate-mediated
tissue damage.
The present biochemical results suggest that MTX in-
jection did not affect levels of TP, ALB and A/G ratio.
The results from MTX treated groups was similar to
those from the MUL+MTX treated group and control
group. This could be possibly explained as Doumas and
Peters [31] reported that any decrease of serum TP and
ALB levels might indicate insufficient hepatocyte biosyn-
thesis. One of the major reasons for a decline in biosyn-
thetic functions is the low protein feeding diet. However,
hence animals in the present study were fed a diet with
suitable protein content, may be the cause of weaker
variation in serum TP and ALB levels.
The biochemical changes induced by MTX treatment
were confirmed by morphometeric and histological studies.
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diagnoses [32]. The liver indices of the experimental rats
were noticeably affected by MTX treatment and regular
oral administration of mulberry leaves extract. The results
from this study show significantly higher HSI in MTX-
treated rats when compared to control. This increase in
liver weight may be probably due to formation of reactive
oxygen species (ROS) which lead to hepatic damage [33]
and liver inflammation [34]. MTX leaded to histopatho-
logical changes including hydropic degeneration, cellular
infiltration and collagen deposition. These results are
confirmed with other previous studies. Soliman [35]
demonstrated that rats received a single injection of
MTX (20 mg/kg, i.p.), exhibited a toxic effect on liver
with plenty of focal sinusoidal areas, portal track in-
flammation, proliferation of Kupffer cells, focal liver
cell necrosis, fibrosis and fatty changes in hepatocytes.
Regarding, the Masson’s Trichrome staining, there was a
progressive increase of collagen deposition after MTX
injection. The present observation is in agreement with
those of Ros et al. [36] who found perisinusoidal fibrosis
due to direct toxic effects of MTX. Also, Hytiroglou et al.
[37] stated that the MTX is known to cause hepatic fibro-
sis in some patients, which might progress to cirrhosis.
MTX is known to cause lipid peroxidation through
generation of ROS which damage the mitochondrial
and cytoplasmic membranes causing more severe oxi-
dative damage in the tissues [27]. This liver cell injury
usually initiate activation of blood-derived phagocytes
that increases the concentration of fibrogenic cytokines
and recruit a lot of fibroblasts and fibroblast-like cells for
excess production of extracellular matrix [27, 38].
According to the present results, the in vitro level of
MUL exhibited inhibition on HepG2 cell line proliferation
with IC50 equal to 14.5 μg /ml. These results are in agree-
ment with previous results on HepG2 cells, showing that
mulberry leaf extracts can inhibit cell proliferation and de-
press the levels of alpha-fetoprotein (AFP) and ALP in
HepG2 cells than controls in a time dependent-manner
[39], as well as through G2/M phase arrest and induction
of apoptosis [40].
With regard to in vivo study, the administration of
ethanolic mulberry leaves extract did not show any ad-
verse affect on liver weight. The administration of MUL
enhanced the hepatosomatic index of MTX treated rats
and brought this parameter back to values very similar to
that observed in the control group. Also, MUL given dur-
ing the MTX application provided significant protection
from the hepatotoxicity of MTX. Treatment with MUL in
combination with MTX apparently exhibited a significant
decrease in AST, ALT, ALP and LDH activities. Recently,
Mallhi et al. [13] reported the hepatoprotective role of
MUL on paracetamol induced liver injury in mice. Also,
protective effect of MUL on rat liver injury in diabetic ratswas demonstrated by Nazari et al. [41]. These studies
showed that black mulberry administration prevented
ALT and AST increase and improved liver function in dia-
betic rats. Moreover, Agha et al. [42] concluded that MUL
juice possess antioxidant properties which could prevent
liver dysfunction induced by CCl4. Thus, the possible
mechanism may be due to free radical scavenger and
antioxidant activities of MUL constituents, especially
flavonoids (i.e., quercetin, rutin, and isoquercitrin) [43, 44].
According to the present results, liver sections of the
rats treated with MUL at a dose of 500 mg/kg followed
by MTX intoxication apparently ameliorated the gross
and histological alterations in hepatic tissue induced by
MTX. A possible mechanism of M. nigra extract as he-
patoprotective may be due to its antioxidant effect, which
can impair the activation of MTX into the reactive form.
Since flavonoids have hepatoprotective activities [45].
Mulberry leaves were shown to contain at least four
flavonoids, including rutin [44, 46, 47]. Flavonoids have
long been recognized to possess hepatoprotective and
anticarcinogenic activities [45, 48]. Moreover, leaves of
mulberry plants have been recently reported to have
antioxidant effect as they contain alkaloid as well as flavo-
noids Radojković et al. [43]. In the present work MUL
administration to the MTX group significantly decreased
the hepatic collagen content and histopathological score.
This results may be due to the presence of flavonoids
which known to possess remarkable antioxidant properties
capable of protecting normal cells from various stimuli-
induced oxidative stress and cell death [49]. The possible
mechanism that is responsible for the protection of MTX-
induced liver damage by mulberry leaves extract may
be due to its radical scavenger activity. By trapping lipid
and peroxyle radicals, MUL could hinder their interaction
with polyunsaturated fatty acids and would abolish the en-
hancement of lipid per-oxidative processes [50].
Although Methotrexate is often the most effective agent
for treating severe rheumatoid arthritis, hepatotoxicity is a
frequent complication of long-term methotrexate therapy,
and can force discontinuation of this drug [51]. According
to considerations cited above likewise imply that MUL
may be administered in conjunction with methotrexate
therapy to encounter its oxidative effect.
Conclusions
In conclusion, the present study clearly demonstrates that
MUL administration protected liver tissues, probably due
to its antioxidant and cytoprotective characteristics. In
addition, the administration of MUL could be used with
chemotherapeutic agents in combination therapy with
MTX-treatment.
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